ROYAL BANK OF CANADA - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 125 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,000484
+384.0%
0.00%
Q1 2023$01000.0%0.00%
Q4 2022$0100
-63.9%
0.00%
Q3 2022$0277
+177.0%
0.00%
Q2 2022$0
-100.0%
100
-97.6%
0.00%
Q1 2022$11,000
-82.8%
4,085
-72.8%
0.00%
Q4 2021$64,000
+82.9%
15,012
+125.3%
0.00%
Q3 2021$35,0000.0%6,662
+20.3%
0.00%
Q2 2021$35,000
+12.9%
5,540
+38.2%
0.00%
Q1 2021$31,000
+3000.0%
4,008
+3908.0%
0.00%
Q4 2020$1,0000.0%100
-39.4%
0.00%
Q3 2020$1,000
-66.7%
165
-40.4%
0.00%
Q2 2020$3,0000.0%277
-15.5%
0.00%
Q1 2020$3,000
-62.5%
328
-65.2%
0.00%
Q4 2019$8,000
+700.0%
942
+842.0%
0.00%
Q3 2019$1,0000.0%1000.0%0.00%
Q2 2019$1,0000.0%1000.0%0.00%
Q1 2019$1,000
-50.0%
1000.0%0.00%
Q4 2018$2,000
-91.3%
100
-91.9%
0.00%
Q3 2018$23,000
+283.3%
1,241
+337.0%
0.00%
Q2 2018$6,0000.0%284
-7.5%
0.00%
Q4 2017$6,000
-86.7%
307
-87.6%
0.00%
Q3 2017$45,000
+4400.0%
2,472
+5393.3%
0.00%
Q2 2017$1,000
-92.3%
45
-93.8%
0.00%
Q1 2017$13,000
+44.4%
727
-15.8%
0.00%
Q4 2016$9,0008630.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders